To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.

Cost and committee reports

Official records Congress.gov attaches to H.R. 9774.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. LATTA, as printed in the Congressional Record (Vol. 172, No. 118, July 20, 2026, Pages H4681-H4682):
  Article I, Section 8, Clause 3: Congress shall have the power . . . ``to regulate Commerce with foreign Nations, and among the several States, and with the Indian tribes.''
  Source: Congress.gov, Congressional Record July 20, 2026 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  172 characters

  Congress.gov bill record

  H.R. 9774, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/9774

  Record last updated by Congress.gov

  July 28, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  02cef20a5f68b00fc82c979f7961d065548fc33c7d1e1dfb3f64e241c171feb9

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 28, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 9774, last updated July 28, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.